These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 11886446)

  • 1. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation.
    Elyaman W; Terro F; Wong NS; Hugon J
    Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassembly.
    Elyaman W; Yardin C; Hugon J
    J Neurochem; 2002 May; 81(4):870-80. PubMed ID: 12065646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
    Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H
    Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules.
    Sang H; Lu Z; Li Y; Ru B; Wang W; Chen J
    Neurosci Lett; 2001 Oct; 312(3):141-4. PubMed ID: 11602330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase.
    Lesort M; Jope RS; Johnson GV
    J Neurochem; 1999 Feb; 72(2):576-84. PubMed ID: 9930729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
    Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S
    J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of glycogen synthase kinase-3beta (GSK-3beta) protein expression during neuroblastoma IMR-32 cell differentiation.
    Muñoz-Montaño JR; Moreno FJ; Avila J; Díaz-Nido J
    J Neurosci Res; 1999 Feb; 55(3):278-85. PubMed ID: 10348658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
    Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
    Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain.
    Takahashi M; Tomizawa K; Ishiguro K
    Brain Res; 2000 Feb; 857(1-2):193-206. PubMed ID: 10700568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
    Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
    Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective loss of basal forebrain cholinergic neurons by 192 IgG-saporin is associated with decreased phosphorylation of Ser glycogen synthase kinase-3beta.
    Hawkes C; Jhamandas JH; Kar S
    J Neurochem; 2005 Oct; 95(1):263-72. PubMed ID: 16181430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes.
    Goldbaum O; Richter-Landsberg C
    Glia; 2002 Dec; 40(3):271-82. PubMed ID: 12420308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
    Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
    Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.
    Kamat PK; Rai S; Swarnkar S; Shukla R; Ali S; Najmi AK; Nath C
    Neuroscience; 2013 May; 238():97-113. PubMed ID: 23415789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
    Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
    Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.
    Pei JJ; Braak E; Braak H; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
    J Neuropathol Exp Neurol; 1999 Sep; 58(9):1010-9. PubMed ID: 10499443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.